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Proper neuronal function and several forms of
synaptic plasticity are highly dependent on pre-
cise control of mRNA translation, particularly
in dendrites. We find that eIF4AIII, a core exon
junction complex (EJC) component loaded
onto mRNAs by pre-mRNA splicing, is associ-
ated with neuronal mRNA granules and den-
dritic mRNAs. eIF4AIII knockdown markedly
increases both synaptic strength and GLUR1
AMPA receptor abundance at synapses.
eIF4AIII depletion also increases ARC, a protein
required for maintenance of long-term poten-
tiation; arc mRNA, one of the most abundant
in dendrites, is a natural target for nonsense-
mediated decay (NMD). Numerous new NMD
candidates, some with potential to affect
synaptic activity, were also identified compu-
tationally. Two models are presented for how
translation-dependent decay pathways such
as NMD might advantageously function as crit-
ical brakes for protein synthesis in cells such as
neurons that are highly dependent on spatially
and temporally restricted protein expression.
INTRODUCTION
In eukaryotes, nearly every aspect of cytoplasmic mRNA
metabolism, including subcellular localization, transla-
tional efficiency, and mRNA half-life, is highly regulated
(Moore, 2005). Cytoplasmic control of gene expression
is particularly important for elaboration of such key asym-
metric functions as cell division, oogenesis, body pattern-
ing, cell motility, and synaptic plasticity (Du et al., 2007;
Steward and Schuman, 2003). In the case of neurons,dendritically localized mRNAs encode membrane recep-
tors, neurotrophins, cytoskeletal proteins, and key regula-
tory kinases that participate in synaptic activity. Local
protein synthesis from dendritic mRNAs is important for
the maintenance of synaptic function as well as several
forms of synaptic plasticity (Amrani et al., 2004; Sutton
and Schuman, 2005; Ule and Darnell, 2006).
Cytoplasmic mRNA metabolism is mediated by a host
of trans-acting factors that, along with the mRNA, form
a messenger ribonucleoprotein particle (mRNP; Kindler
et al., 2005). Many cytoplasmic mRNP constituents are
initially acquired in the nucleus; thus the nuclear history
of an mRNA is of significant consequence for its cytoplas-
mic fate (Czaplinski and Singer, 2006; Farina and Singer,
2002; Giorgi and Moore, 2007). One clear example is
oskar mRNA, whose localization at the posterior pole of
Drosophila oocytes requires the transcript to have under-
gone pre-mRNA splicing (Hachet and Ephrussi, 2004).
Trans-acting factors required for this process include
eIF4AIII, BARENTSZ, TSUNAGI, and MAGO NASHI, the
Drosophila homologs of mammalian eIF4AIII, MLN51,
Y14, and MAGOH, respectively (Palacios et al., 2004;
and references therein). These four proteins constitute
the core of a larger assemblage known as the exon junc-
tion complex (EJC; Ballut et al., 2005; Tange et al., 2005).
EJCs are deposited on mRNAs upstream of exon–exon
junctions in a manner independent of sequence and as
a consequence of pre-mRNA splicing (Le Hir et al.,
2000; Tange et al., 2004). Structurally, the EJC consists
of a stably-bound tetrameric core that serves as a binding
platform for other more transiently associated factors.
Within this core, the DEAD-box protein eIF4AIII collabo-
rates with its binding partner MLN51 to serve as the
main RNA binding constituent (Ballut et al., 2005; Shibuya
et al., 2004). EJCs travel with spliced mRNAs to the cyto-
plasm, where those located within open reading frames
(ORFs) can be positive effectors of ribosome recruitment
(Nott et al., 2004) prior to their displacement by the first
or ‘‘pioneer’’ round of translation (Dostie and Dreyfuss,Cell 130, 179–191, July 13, 2007 ª2007 Elsevier Inc. 179
2002; Ishigaki et al., 2001). Conversely, EJCs located
downstream of an ORF can trigger nonsense-mediated
mRNA decay (NMD; Conti and Izaurralde, 2005). In mam-
mals, NMD substrates are presumably targeted for decay
coincident with the pioneer round (Ishigaki et al., 2001).
This targeting involves interaction between the key NMD
factor UPF1 and a ribosome stalled at a termination
codon. UPF1 recruitment occurs by way of its interaction
with UPF2 and UPF3, which directly associate with any
downstream EJCs. This pathway not only serves to down-
regulate aberrant mRNAs (e.g., those produced from
mutant alleles or by improper pre-mRNA processing), it
also modulates protein expression from natural NMD
targets. Such natural targets include mRNAs containing
upstream open reading frames (uORFs) and those pro-
duced from transcripts harboring introns in the 30-UTR
(Hillman et al., 2004; Mendell et al., 2004; Wittmann
et al., 2006).
During Drosophila oocyte maturation, all four EJC core
factors accumulate at the posterior pole along with oskar
mRNA. Also exhibiting this same localization pattern is
STAUFEN, a double-stranded RNA-binding protein re-
quired for both transport and regulated translation of
oskar (Micklem et al., 2000; St Johnston, 2005). In addition
to its role in oogenesis, STAUFEN has been implicated as
an mRNA transport factor in both Drosophila and mam-
malian neurons (Kiebler et al., 1999; Li et al., 1997). In
Drosophila neurons, dendritic STAUFEN granules contain
UPF1 and other factors involved in mRNA translational
regulation and decay (Barbee et al., 2006). In mammalian
neurons, both ubiquitous STAUFEN1 (STAU1) and brain-
specific STAUFEN2 (STAU2) exhibit somatodendritic
localization, and STAU1 has been shown to function in
the dendritic delivery of some mRNAs (Kanai et al., 2004;
Tang et al., 2001). Also exhibiting dendritic localization in
mammalian neurons are the EJC core factors MLN51,
Y14, and MAGOH (Glanzer et al., 2005; Macchi et al.,
2003; Monshausen et al., 2004), although no functional
consequence of this localization has yet been reported.
Here we investigated participation of the key EJC factor
eIF4AIII (referred to hereafter as 4AIII) in mRNA expression
in mammalian neurons. Functionally, 4AIII knockdown in
neurons leads to increased miniature excitatory postsyn-
aptic currents (mEPSCs) and increased abundance of
the AMPA receptor GLUR1 at synapses. Structurally,
4AIII is associated with neuronal mRNA transport granules
and dendritic mRNAs. One such mRNA, arc (encoding
the Activity-regulated cytoskeletal-associated protein;
Arg3.1), is a natural target for NMD by virtue of two EJCs
situated on its 30-UTR. Bioinformatic analysis indicates
that several other brain-expressed mRNAs, as well as
numerous mRNAs in other tissues, could be regulated in
an analogous fashion. Finally, two models are presented
for how translation-dependent mRNA decay pathways
such as NMD might advantageously function as critical
brakes on protein synthesis in cells such as neurons that
are highly dependent on precise control of protein expres-
sion in the cytoplasm.180 Cell 130, 179–191, July 13, 2007 ª2007 Elsevier Inc.RESULTS
4AIII Displays Somatodendritic Localization in Rat
Hippocampal and Cortical Neurons
In HeLa cells, 4AIII exhibits primarily nuclear localization
(Figure 1A; Palacios et al., 2004; Shibuya et al., 2004).
To examine its distribution in neurons, we used an antise-
rum against human 4AIII that also recognizes the rat pro-
tein (Figure S1A). The hippocampus is particularly well
suited for examining subcellular compartmentalization of
neuronal proteins because cell bodies and neurites reside
in separate and easily distinguishable layers (Figure 1B,
left panel). Immunofluorescence of coronal brain sections
revealed endogenous 4AIII in the dendritic layer as well as
the nuclear and cytoplasmic (somatic) compartments of
neurons within the CA1 field (Figure 1B, right panels).
Other hippocampal fields (e.g., dentate gyrus; Figure S3)
displayed similar 4AIII distributions. We also examined
4AIII localization in cultured rat cortical neurons. Whereas
4AIII was primarily nuclear in the glial feeder cells (similar
to HeLa; Figure S1B, top panels), cortical pyramidal
neurons showed both somatic and dendritic staining
similar to the hippocampal neurons (Figure 1C). An analo-
gous distribution pattern was observed using a different
a-4AIII serum (Figure S1B, bottom panels). Thus, in both
brain sections and cultured neurons, a significant fraction
of 4AIII resides outside the nucleus.
4AIII Colocalizes and Physically Associates
with Known Dendritic mRNP Proteins
In both dendrites and somata of cultured neurons, endog-
enous 4AIII exhibited extensive colocalization with two
well-known dendritic mRNP proteins, STAU1 (Figure 1D)
and the FRAGILE X protein (FMRP; Figure 1E). FMRP is
a translational repressor of dendritic mRNAs and asso-
ciates with neuronal mRNA transport granules (Kanai
et al., 2004; Vanderklish and Edelman, 2005). Immunopre-
cipitation (IP) assays confirmed a RNA-dependent bio-
chemical association between 4AIII and FMRP in brain
lysates (Figure S1C). Taken together, these data suggest
that 4AIII is associated with FMRP and STAU1 in dendritic
mRNPs.
Also colocalizing with FMRP was the essential NMD
factor UPF1, which like 4AIII, distributes throughout
somata and dendrites (Figure 1F). This observation nicely
parallels recent data showing that UPF1 and other factors
involved in mRNA decay and microRNA function colocal-
ize with STAUFEN- and FMRP-containing granules in
Drosophila neurons (Barbee et al., 2006).
4AIII Associates with Dendritic mRNAs
To test directly the idea that 4AIII is physically associated
with dendritic mRNAs, cytosolic extracts of rat cortex
were incubated with a-4AIII or nonimmunized (rIgG)
rabbit serum, and the immunoprecipitated complexes
were analyzed by semiquantitative RT-PCR (Figure 2A).
For dendritic mRNAs, we chose arc, dendrin, map2,
camkIIa, gluR1, and grin1, all of which have been
Figure 1. 4AIII Exhibits Somatodendritic Localization in Neurons and Colocalizes with STAU1 and FMRP
(A) HeLa cells stained for DNA (blue) and endogenous 4AIII (green; scale bar: 30 mm).
(B) Left: Coronal slice (p25 rat; 25 days old) showing hippocampus stained for DNA (blue) and the CA1 field (white box) enlarged in middle and right
panels, which show DNA (blue) and endogenous 4AIII (green; scale bar: 30 mm).
(C) Endogenous 4AIII (green) and MAP2 (red) in DIV7 cultured cortical neurons. MAP2 allows for visualization of dendrites.
(D–F) Colocalization of endogenous eIF4AIII or UPF1 (central panels; red) with exogenous STAU1-YFP or endogenous FMRP (left panels; green) in
cultured cortical neurons. Right panels: merged signals. Lower panels: enlargements of indicated (white box) dendritic regions.
(In [C]–[F] scale bar is 10 mm).documented to exhibit dendritic localization (Ju et al.,
2004; Steward and Schuman, 2003). For comparative pur-
poses, we also analyzed three housekeeping mRNAs that
encode essential components of the glycolytic pathway:
gapdh, phgdh, and pgam1 (Table S1). For all three house-
keeping mRNAs, very little precipitation was observed
with either a-4AIII or nonimmune serum. In contrast, all
six dendritic mRNAs were significantly enriched in a-
4AIII precipitates. This preferential association could be
quantified by normalizing all IP efficiencies to that ofgapdh (Figure 2B). Whereas all three housekeeping
mRNAs exhibited very low coIP efficiencies, the dendritic
mRNAs were between 5- and 30-fold enriched in the
a-4AIII pellet compared to gapdh. Thus 4AIII exhibits
preferential association with dendritic mRNAs.
Arc mRNA Is a Natural Target for NMD
Within the dendritic set, arc mRNA exhibited the greatest
fold enrichment upon a-4AIII IP (Figure 2B). Examination
of the arc gene revealed it to have a conserved and highlyCell 130, 179–191, July 13, 2007 ª2007 Elsevier Inc. 181
Figure 2. 4AIII Associates with Dendritic
mRNAs and Modulates Arc mRNA, a
Natural NMD Substrate
(A) Semiquantitative RT-PCR of RNA samples
immunoprecipitated from cytosolic cortex
extracts with either a-4AIII or control (rabbit
IgG; rIgG) serum.
(B) Relative mRNA enrichment upon a-4AIII IP
determined by subtracting control serum IP
values from 4AIII-IP values, dividing the result
by input (total) for that mRNA, and then normal-
izing all values to that obtained for Gapdh
mRNA. Bars are averages of four data points
from two separate experiments ± standard
deviation (SD).
(C) Schematic representation of mammalian
arc gene: 50- and 30-UTRs (gray boxes), ORF
(black box), and introns (lines).
(D–G) RNAi knockdown of 4AIII (D–E) or UPF1
(F–G) in PC12 cells. Western blot signals for
4AIII (D), UPF1 (F), and ARC were normalized
to those for MAGOH. (E and G) Semiquantita-
tive RT-PCR signals for arc, egr1, and egr3
mRNAs were normalized to those of map1
mRNA; reported values are averages of three
independent experiments ± SD.unusual structure. In the three mammalian genomes for
which arc pre-mRNA splicing patterns could be confirmed
with extensive EST data (human, mouse, and rat), only two
introns are apparent, and both are located in the 30-UTR
(Figures 2C and S2). This contrasts with the vast major-
ity of mammalian genes, where introns are generally
excluded from this region because EJC deposition down-
stream of a termination codon can induce NMD of the
product mRNA (see Introduction). Thus mammalian arc
mRNA would appear to be a natural NMD target.
To examine the possibility that EJC deposition plays
a role in modulating arc expression, we performed RNAi
knockdown of 4AIII in rat PC-12 cells. This neuroendo-
crine cell line was previously utilized to monitor arc
mRNA abundance in response to depolarization and/or
translational inhibitors (Ichikawa et al., 2003; Waltereit
et al., 2001). Whereas 88% knockdown of endogenous
4AIII resulted in a 2-fold increase in arc mRNA (Figures
2D and 2E), another dendritic mRNA, map1, was unaf-
fected. Also unaffected were two other immediate early
mRNAs, egr1 and egr3, indicating that the increase in
arc expression upon 4AIII knockdown was not due to
transcriptional activation. Consistent with elevated arc
mRNA, ARC protein levels increased 4-fold upon 4AIII
depletion (Figure 2D). Coexpression of an exogenous, RNAi-
immune human 4AIII construct restored ARC protein182 Cell 130, 179–191, July 13, 2007 ª2007 Elsevier Inc.levels to their endogenous state, validating the specificity
of the 4AIII knockdown (Figure S2C).
To confirm that the increases in arc mRNA and protein
levels upon 4AIII knockdown were due to disruption of
NMD, we repeated the RNAi analysis, targeting instead
the essential NMD factor UPF1 (Figure 2F). As observed
for knockdown of 4AIII, Arc mRNA levels increased upon
Upf1 depletion, whereas map1, egr1, and egr3 mRNA
levels were unaffected (Figure 2G). ARC protein levels
also increased in UPF1 knockdown cells (Figure 2F). We
conclude that arc mRNA is a natural NMD target.
4AIII Remains Associated with arc mRNA
upon Induction
Arc is an immediate early gene whose mRNA traffics to
dendrites and accumulates at activated synapses. Arc
expression is modulated by neuronal activity and is
required for both maintenance of long-term potentiation
(LTP) and long-term memory consolidation (Plath et al.,
2006; Steward and Worley, 2002; Tzingounis and Nicoll,
2006). Activity-dependent upregulation of arc mRNA and
protein can be strongly induced in vivo by electrocon-
vulsive or kainic acid-induced seizures, with particular
accumulation in the dentate gyrus (Wallace et al., 1998;
Waltereit et al., 2001). This effect can be recapitulated
in vitro by stimulation of cultured neurons with, for
example, brain-derived neurotrophic factor (BDNF; Rao
et al., 2006).
Having observed a strong association between 4AIII
and arcmRNA in brain extracts under unstimulated condi-
tions (Figures 2A and 2B), we next assessed whether any
change in this interaction occurred upon arcmRNA induc-
tion. To do so, we examined the association of arcmRNA
with 4AIII in the dentate gyrus or in cultured cortical
neurons pre- and post-kainic-acid-induced seizure or
BDNF treatment, respectively. Both protocols significantly
increased overall arcmRNAand protein levels (Figures 3A,
S3, and S4A), and these increases were apparent in both
somata and dendrites (Figures 3B and S3). IP of cytoplas-
mic extracts from dissected dentate gyrus or cultured
neurons revealed that 4AIII was equally associated with
arc mRNA pre- and postinduction (Figures 3C and S4B).
Thus, even when arc mRNA is strongly induced, its asso-
ciation with 4AIII is unperturbed. This suggests that arc
mRNA is subject to NMD even when it accumulates in
response to strong stimuli.
To rule out the possibility that 4AIII association with
induced arc mRNA is limited to the somatic compart-
ment, we also analyzed their colocalization in dendrites
(Figure 3D). Of 360 dendritic granules analyzed from
six neurons following BDNF treatment, 59% of arc
mRNA granules colocalized with 4AIII. On the other
hand, colocalization of 4AIII with arc mRNA accounted
for only 29% of 4AIII puncta, most likely reflecting asso-
ciation of 4AIII with other dendritic mRNPs. Indeed, our
data indicate that only upon induction does the level of
Arc mRNA approach those of other dendritic mRNAs
(note that in both Figures 2A and 3C, RT-PCR reactions
for Arc contained ten times more total RNA than those
for other dendritic mRNAs). Further, we observed no
significant changes in either the overall levels or subcel-
lular distribution of 4AIII upon arc induction in either the
dentate gyrus or cultured neurons (Figures S3 and
S4C). This is the expected result if arc represents just
a fraction of dendritic mRNA.
4AIII Knockdown Increases arc mRNA and Protein
Abundance in Neurons
Having shown that the association of 4AIII with arc
mRNA is unperturbed upon induction, we next analyzed
the effects of 4AIII knockdown on arc mRNA and protein
levels after BDNF treatment. Coexpression of shRNAs
and eGFP from a single plasmid allowed for ready
identification of transfected neurons; downregulation of
endogenous 4AIII was confirmed by immunofluorescence
(Figure S5A). Upon 4AIII knockdown arc mRNA and
protein levels increased in both somata and dendrites
(Figures 4A, 4B and S5B). These mRNA and protein
increases were confirmed quantitatively by cumulative
frequency analysis (Figure 4, right panels). Significantly,
upon 4AIII knockdown, ARC protein levels increased not
only in somata and dendrites, but also at synapses
(Figure 4B).4AIII Knockdown Increases Excitatory
Synaptic Strength
Having shown that 4AIII knockdown changed the levels of
at least one protein at synapses, we next sought to inves-
tigate the effects of 4AIII knockdown on postsynaptic
strength. We recorded excitatory miniature postsynaptic
currents (mEPSCs) mediated by AMPA receptors (Turri-
giano et al., 1998; Watt et al., 2000) in cortical neurons.
Individual mEPSCs (Figure 5A) reflect the postsynaptic
response to release of individual neurotransmitter vesi-
cles; mEPSC amplitude is generally thought to reflect
the number of AMPA receptors present in the postsynap-
tic membrane, whereas mEPSC frequency is dependent
on the number of functional synaptic contacts and the
probability of spontaneous vesicle fusion.
We recorded from untransfected neurons and from neu-
rons transfected with either the 4AIII-RNAi or a control-
RNAi plasmid (DIV7). By expressing the shRNA constructs
at very low efficiency (10–20 neurons/culture dish) we
could test the effects of 4AIII knockdown in postsynaptic
neurons without affecting 4AIII expression presynaptically
and without perturbing network activity. Knockdown of
4AIII approximately doubled mEPSC amplitude (Figures
5A, 5B, and 5C) without affecting mEPSC frequency
(Figure 5C) or passive cellular properties such as input
resistance and resting potential. 4AIII knockdown de-
creased the rise time constants of the mEPSCs slightly
(Figures 5B and 5C; p < 0.01), and there was a nonsignifi-
cant trend toward reduction in the decay time constant;
these small changes in kinetics could reflect changes in
receptor properties.
To determine whether the observed changes in mEPSC
amplitude caused by 4AIII knockdown were associated
with changes in AMPA receptor abundance at synapses,
we compared the amounts of synaptic GLUR1 in neurons
transfected with either a 4AIII- or control-RNAi plasmid.
Coimmunofluorescence of the presynaptic marker synap-
sin and surface GLUR1 revealed a marked increase of
this AMPA receptor at putative synaptic sites upon 4AIII
knockdown (Figure 5D).
Overall, we find that 4AIII knockdown leads to an
increase in mEPSC amplitude and a corresponding
increase of GLUR1 receptor levels at synapses. These
data indicate that 4AIII normally acts as a brake on synap-
tic strength so that reducing levels of 4AIII leads to a
dramatic increase in quantal synaptic transmission.
Bioinformatics Reveals a Set of Genes Containing
Conserved 30-UTR Introns
In light of recent evidence that ARC protein overexpres-
sion leads to decreased GLUR1 levels at synapses (see
Discussion), our observation that 4AIII knockdown in-
creased synaptic GLUR1 was unexpected. A simple inter-
pretation is that arc is not the only dendritic mRNA af-
fected by 4AIII depletion. We therefore sought to identify
other potential targets for regulation by 4AIII via its ability
to induce NMD when bound downstream of a natural
stop codon. Previous studies that aimed to identify suchCell 130, 179–191, July 13, 2007 ª2007 Elsevier Inc. 183
Figure 3. No Change in 4AIII:Arc mRNA Association upon Arc Induction
(A)Arc andmap2mRNAs levels pre- and postinduction (calculated comparing RT-PCR input levels in [C]. Seizure: kainic acid-induced seizure of adult
rats; +BDNF: treatment of cultured neurons with BDNF.
(B) Left: FISH of arcmRNA (top panels) and immunofluorescence of ARC protein (bottom panels) in cultured neurons pre- and post-BDNF treatment.
MAP2 (green inset) allows for visualization of dendrites. Middle panels: Enlargements of boxed dendritic regions. Right: Relative intensities of arc
mRNA and protein before and after induction in soma and dendrites. Bars are averages of two separate experiments ± standard deviation (SD).
(C) Semiquantitative RT-PCR of RNA samples immunoprecipitated from cytosolic extracts of dissected dentate gyrus (top) or cultured cortical
neurons (bottom) with either a-4AIII or control (rabbit IgG; rIgG) serum. Relative a-4AIII IP efficiencies ± SD are reported at right.
(D) FISH of arc mRNA (red) and immunofluorescence of 4AIII (green) after BDNF treatment. Right panels: enlargement of indicated dendritic region.
Arrows indicate examples of colocalization. (In [B] and [D] scale bar is 10 mm).natural mammalian NMD targets employed microarray
analysis of UPF1- or UPF2-depleted cells (Mendell et al.,
2004; Wittmann et al., 2006). However, arc mRNA was
not identified in either study, likely because it is poorly
expressed in the cell type (HeLa) examined (data not184 Cell 130, 179–191, July 13, 2007 ª2007 Elsevier Inc.shown). Therefore other potential targets may have been
missed as well.
An alternate approach for the prediction of NMD targets
is to search for conserved 30-UTR introns computationally.
In order to generate a biologically important set of
Figure 4. 4AIII Knockdown Increases arc mRNA and Protein Levels in Neurons
(A and B) GFP-positive cells (green): neurons transfected with control-RNAi (left panels) or 4AIII-RNAi (right panels) plasmid. Following BDNF treat-
ment, neurons were subjected to immunofluorescence of GFP and either (A) FISH of endogenous arcmRNA (red) or (B) immunofluorescence of ARC
protein (red) and the presynaptic marker SYNAPSIN1 (blue). Right panels: Cumulative histograms quantifying the distribution of arcmRNA and ARC
protein in soma (A and B), dendrites (A and B) and synapsin-positive spines (B) of neurons that were either untransfected, transfected with control-
RNAi plasmid, or transfected with 4AIII-RNAi plasmid. Distributions are representative of at least two separate experiments. Arrows indicate exam-
ples of SYNAPSIN-positive spines. Relative distribution of ARC protein in transfected versus untransfected neurons is shown in Figure S5.candidates, we focused on identifying human genes
where any annotated 30-UTR intron contains canonical
splice signals (GT-AG) that are evolutionarily conserved
across multiple mammalian species. As schematized in
Figure 6, we implemented an algorithm to identify geneswhere: (1) alignment of known transcripts to the human
genome indicates the presence of at least one 30-UTR
intron; (2) the 50 and 30 splice sites are conserved across
human, rat, and mouse; (3) the 30-UTR intron is at least
30 bases long to avoid mistakes in aligning transcripts toCell 130, 179–191, July 13, 2007 ª2007 Elsevier Inc. 185
Figure 5. 4AIII Knockdown Increases
Excitatory Synaptic Transmission and
GLUR1 Levels at Synapses
(A) Example of mEPSC recordings from neu-
rons transfected with either control or 4AIII-
RNAi plasmid.
(B) Average mEPSCs from control (black trace,
n = 10) or 4AIII-RNAi (gray trace, n = 11) neu-
rons, constructed by averaging all mEPSCs
from each neuron and then generating
a meta-average for each condition. Scaling
the control average mEPSC to the same ampli-
tude as the 4AIII-RNAi average reveals small
changes in mEPSC kinetics (dotted line).
(C) Average mEPSC amplitude (p < 0.001), fre-
quency (p = 0.41), rise times (p < 0.02), and
decay times (p = 0.22).
(D) DIV7 neurons transfected with either con-
trol-RNAi (left panels) or 4AIII-RNAi (right
panels) plasmid (green) were stained for SYN-
APSIN (blue) and surface GLUR1 (red; scale
bar is 10 mm). Top right panels: enlargement
of indicated dendritic regions. Bottom right
panel: cumulative histogram representing the
mean intensity distribution of SYNAPSIN-
positive GLUR1 puncta. For each condition,
12 neurons and a total of 200 synapses
from termini of apical dendrites were analyzed.
The distribution is representative of three sepa-
rate experiments.the genome; (4) the intron is at least 50 nucleotides down-
stream of the conserved stop codon so that the deposited
EJC could serve as a trigger for NMD; and (5) there is no
alternative splice form in which the splice junction falls
within an ORF. The latter requirement ensured that intron
conservation was independent of any coding capacity of
the flanking exons. This protocol led us to the identifica-
tion of 152 candidate transcripts from 149 genes in which
the conservation of an intron in the 30-UTR is likely due to
some functional role of splicing in that region (Spread-
sheet S1). Included in this list are numerous proteins that
have been implicated in synapse formation or function, in-
cluding twocadherins, a neurexin, a neuregulin, a synapto-
tagmin, and several ion channels.
Using available microarray data from (Su et al., 2004),
we also generated a scaled expression profile map for
135 probe-sets that were found to represent 120 of the
152 candidate NMD transcripts (http://expression.gnf.
org; Figure S6). Examination of this map reveals several
interesting clusters including 5–7 mRNAs expressed
primarily in the brain, 6 mRNAs highly enriched in testis,
and 40 mRNAs highly expressed across multiple tissues.186 Cell 130, 179–191, July 13, 2007 ª2007 Elsevier Inc.The largest cluster comprises 44 mRNAs primarily ex-
pressed in peripheral blood and bone marrow. Thus it
would appear that some feature of hematopoietic cells
may particularly favor evolution of genes containing
30-UTR introns.
DISCUSSION
4AIII Is a Component of Neuronal Transport Granules
and Regulates arc Expression
This study reveals a novel role for 4AIII and NMD in
regulating the expression of arc, one of the best-studied
dendritic mRNAs. ARC affects neuronal plasticity pro-
cesses and is essential for the consolidation of long-
term memory (Guzowski et al., 2000; Plath et al., 2006;
Steward andWorley, 2002). Upon intense synaptic activa-
tion, the arc gene is induced transcriptionally. A portion of
this newly made mRNA is delivered to dendrites, where it
specifically localizes to activated synapses in a NMDA
receptor-dependent manner and is thought to be locally
translated (Steward et al., 1998; Steward and Worley,
2001). Mechanistically, ARC protein was recently
demonstrated to regulate synaptic scaling and trafficking
of AMPA receptors (Chowdhury et al., 2006; Rial Verde
et al., 2006; Shepherd et al., 2006).
Previous studies had shown that inhibitors of transla-
tion led to marked increases in arc mRNA abundance,
suggesting that arc mRNA is somehow destabilized
upon translation (Ichikawa et al., 2003; Steward et al.,
1998; Steward and Worley, 2001; Wallace et al., 1998).
Our data readily explain this by demonstrating that arc
mRNA is a natural NMD target. Mammalian arc genes
share the unusual and conserved feature of harboring
two 30-UTR introns. We showed that both arc mRNA and
ARC protein levels increase in PC-12 cells upon shRNA-
mediated depletion of either 4AIII or UPF1. Analogous
increases in arc mRNA and protein levels were also
observed upon 4AIII depletion in cortical neurons, yet
the subcellular arc mRNA and protein distributions were
unaffected. These latter results indicate that 4AIII and,
by inference, the EJC are not required for the dendritic
Figure 6. Bioinformatic Strategy to Screen for Potential NMD
Target Genes
Strategy utilized to identify mammalian transcripts naturally suscepti-
ble to NMD by virtue of a conserved intron in the 30UTR >50 nucleo-
tides downstream of the stop codon.localization of arc mRNA. Rather, by targeting arc mRNA
for destruction upon translation, 4AIII serves as a general
brake on ARC protein expression.
Putting the Brakes on Protein Synthesis via
Translation-Dependent mRNA Decay
Using a bioinformatic approach, we identified 152
transcripts from 149 different genes harboring 30-UTR
introns conserved across multiple mammalian species.
Whereas a few of these transcripts had previously been
shown to be affected by UPF1 knockdown in HeLa cells
(Table S2), most had not. The advantage of our bioinfor-
matic approach was that it relied on splice site conserva-
tion across species rather than chance mRNA expression
in a particular cell type. By limiting our list to 30-UTR introns
conserved across multiple species, our pool should be
highly biased toward genes whose proper expression is
dependent on this unusual structural feature. It has been
estimated that 35% of all alternatively spliced mRNA
isoforms are targets of NMD and that by eliminating
such transcripts, NMD serves to mute genomic noise
(Mendell et al., 2004). However, since we also limited our
final candidate pool to those genes in which the 30-UTR
intron is never coding, our set likely represents a separate
class of transcripts for which the presence of a 30-UTR
intron confers some specific selective advantage.
In all organisms tested to date, including mammals,
NMD is not strictly EJC dependent—30-UTR length and
UPF1-interacting proteins are also key determinants
(Amrani et al., 2006; Buhler et al., 2006; Weil and Beemon,
2006). For example, when bound to the 30-UTR, STAU1
can elicit translation-dependent mRNA decay through its
direct interaction with Upf1 (STAUFEN-mediated mRNA
decay [SMD]; Kim et al., 2005). Given that STAU1 is known
to associate with dendritic mRNA transport granules,
numerous neuronal mRNAs may also be natural SMD
targets.
NMD and SMD are two specific examples of a broader
phenomenon we will term collectively ‘‘translation-depen-
dent mRNA decay’’ (TDD). What might be the benefits of
intentionally targeting mRNAs to TDD? In the case of
ARC, our data indicate that TDD serves as a natural brake
on ARC protein expression throughout the cell. Upon
BDNF induction of cultured neurons, arc mRNA and
protein levels increased in both somata and dendrites. In
both compartments, arc mRNA and protein levels were
further enhanced by 4AIII knockdown. A simple interpreta-
tion is that arc mRNA is translated and subject to NMD in
both somata and dendrites. Additionally, 4AIII knockdown
increased the level of ARC protein at synapses, and there
were no overall changes in the association of 4AIII with
arc mRNA under two different induction regimens. Thus
it would appear that the targeting of arc to NMD is neither
modulated at synapses nor by synaptic activation. Rather,
NMD simply limits the number of protein molecules
synthesized per Arc mRNA, wherever that mRNA mole-
cule is translated in the cell (Figure 7, upper panel).Cell 130, 179–191, July 13, 2007 ª2007 Elsevier Inc. 187
For mRNAs subject to tighter spatial and/or temporal
translational regulation, one can imagine two further
advantages of TTD. First, TDD could act as a brake to
create a strictly limited burst of protein synthesis upon
translational activation at the target location. Because
TDD substrates are stable as long as they remain transla-
tionally silent, such mRNAs could accumulate at high
levels in distal reaches of the cytoplasm (such as neuronal
dendrites), where they would be poised for rapid response
to an external signal. Upon translational activation, TDD
would quickly curtail protein synthesis, producing a tightly
time-limited, quantity-limited, andmRNA-specific transla-
tional response. This mechanism could certainly apply to
those arc mRNA molecules localized to dendrites. If TDD
operates at synapses in this way, it would parallel emerg-
ing data that synaptic protein abundance is also limited by
activity-dependent activation of the proteasome (Bingol
and Schuman, 2005, 2006).
An alternate possibility is that, for some mRNAs, TDD
could serve to prevent improper protein synthesis at
undesired times or locations. For example, if a translation-
ally silenced mRNA lost a key inhibitory factor during
transport and became inappropriately activated, TDD
would quickly eliminate that mRNA. In this scenario, trans-
lational activation at the target location might be accom-
panied by release from TDD (e.g., by removal of the TDD
triggering factors), allowing both the mRNA and protein
to accumulate there (Figure 7, lower panel). Such a model
parallels the activity-dependent relief of dendritic mRNAs
frommicroRNA-mediated repression recently observed in
rat and Drosophila neurons (Ashraf et al., 2006; Schratt
et al., 2006).
Figure 7. Models by which Translation-Dependent mRNA
Decay Could Modulate Neuronal Protein Expression
TDD indicates ‘‘translation-dependent mRNA decay.’’188 Cell 130, 179–191, July 13, 2007 ª2007 Elsevier Inc.A Role of 4AIII in Regulating Synaptic Strength
Electrophysiological recordings demonstrated that 4AIII
knockdown in cultured cortical neurons doubled mEPSC
amplitude (Figure 5). Functionally this is a dramatic
change in synaptic transmission, equivalent in magnitude
to changes produced by several forms of long-lasting
synaptic plasticity such as long term potentiation
(Malenka and Bear, 2004) and synaptic scaling (Turrigiano
and Nelson, 2004). Changes in mEPSC amplitude could
come about through changes in packaging of glutamate
into presynaptic vesicles or through changes in the
number or composition of postsynaptic AMPA receptors
(Malenka and Bear, 2004; Sutton et al., 2006). Because
4AIII was depleted only in the postsynaptic neuron, an
effect on presynaptic glutamate packaging is unlikely,
pointing toward a role for 4AIII in regulation of postsynap-
tic AMPA receptors. Indeed, we found that 4AIII depletion
resulted in a significant increase in surface GLUR1 at
putative postsynaptic sites.
Recently, genetic knockout of arc was shown to
increase both synaptic strength and the number and
intensity of GLUR1 puncta. Conversely, ARC overexpres-
sion in cultured hippocampal neurons led to a defect in
TTX-induced synaptic scaling and a marked reduction of
surface GLUR1 (Chowdhury et al., 2006; Shepherd et al.,
2006). Given that depletion of 4AIII in cultured cortical
neurons leads to increases in ARC throughout the cell
(Figure 4), the above results are in apparent conflict with
the opposite effect on synaptic strength and GLUR1
abundance we observed in 4AIII-depleted neurons (Fig-
ure 6). However, numerous kinases and scaffolding pro-
teins have been shown to regulate the trafficking and/or
properties of synaptic AMPA receptors. There are thus
many potential routes through which 4AIII, by influencing
the local composition of synaptic proteins, could influence
synaptic strength. Our bioinformatic analysis, for example,
revealed a number of other mRNAs expressed in the brain
in addition to arc that arepotential targets of 4AIII regulation
via NMD. Regardless, our data clearly indicate that 4AIII
does play a critical role in maintaining synaptic strength
and suggest that local synthesis of proteins subject to
regulation by 4AIII could contribute to synaptic plasticity.
Dendritic mRNAs and the Pioneer Round
of Translation
Given that most EJCs are displaced by the first or
‘‘pioneer’’ round of translation, the association of EJC
proteins with cytoplasmic mRNAs reports on their transla-
tional history. Previous studies had shown that the EJC
core factor 4AIII, a known nucleocytoplasmic shuttling
protein, exhibits almost exclusive nuclear localization in
nongermline cells. Presumably in the cell types examined
(e.g., HeLa), the majority of mRNAs are translated soon af-
ter nucleocytoplasmic export, allowing rapid recycling of
4AIII to the nucleus. In neurons, however, a distinct subset
of mRNAs is translated in a temporally and spatially
restricted manner (reviewed in Kindler et al., 2005; Klann
and Dever, 2004). Our finding that 4AIII is associated
with both dendritic mRNAs and neuronal transport gran-
ules supports the idea that at least a portion of these local-
ized mRNAs are translationally silent. It further indicates
that these silent mRNAs experienced no pioneer round
of translation in the soma prior to their dendritic localiza-
tion. This is also true of arc mRNA; even though both its
EJCs are located in the 30-UTR and would not be subject
removal by a pioneer round, this same feature destabilizes
arc mRNA upon translation. In mammalian cells, all avail-
able evidence indicates that NMD occurs coincident with
the pioneer round (Maquat, 2004). So in the case of arc
mRNA, its mere presence in the dendrite can be consid-
ered strong evidence that those mRNA molecules have
not yet undergone a pioneer round.
A growing number of studies in diverse cell types sug-
gest that much of cytoplasmic mRNP assembly occurs
within the nuclear compartment (Czaplinski and Singer,
2006; Giorgi and Moore, 2007). In addition to the EJC,
other examples of nuclear-acquired mRNP components
that modulate cytoplasmic mRNA expression include the
zipcode-binding (ZBP) and hnRNPA/B families of pro-
teins. STAUFEN and FMRP have also been reported to
shuttle between the nucleus and the cytoplasm, possibly
assemblingwith their mRNA targets in the nucleus (Kiebler
et al., 2005; Lai et al., 2006). If many such factors neces-
sary for mRNA localization and regulated expression in
the cytoplasm are acquired in the nucleus, then retention
of these key proteins likely necessitates special precau-
tions to avoid a pioneer round of translation immediately
upon nucleocytoplasmic export.
EXPERIMENTAL PROCEDURES
Plasmids, buffers, antibodies, primer sequences, and sources are
described in Supplemental Data.
Seizures, Brain Extracts, and Coronal Slices
All experimental procedures involving animals conformed to NIH
guidelines and were carried out with approval of the Brandeis Animal
Care and Use Committee. Seizures were induced by intraperitoneal
kainic acid injection (12 mg/kg); control animals received comparable
injections of vehicle. Animals were anesthetized and sacrificed 1 hr af-
ter seizure onset. For cytosolic extract preparations, visual cortex (p27
rats) or dentate gyrus (adult rats) was isolated in ACSF and homoge-
nized manually in Lysis Buffer 150 with 20 strokes in a 2 ml Wheaton
dounce homogenizer. Following two rounds centrifugation (10 min
each at 1K 3 g, and 10K 3 g), supernatant (cytosolic fraction; 20
mg protein/ul) was utilized for subsequent IP or western blot analysis.
For immunofluorescence analysis of coronal hippocampal slices,
anesthetized p24–27 rats were perfused with PBS intracardiacally
followed by fixing solution. Fixed brains were cut in 50 mm thick slices.
Cell Cultures, Transfections, Extract Preparation, and BDNF
Treatment
Visual cortical cultures were derived from p3–5 Long-Evans rat pups
as previously described (Turrigiano et al., 1998; Watt et al., 2000), ex-
cept neurons were plated onto astrocyte beds and supplemented with
B27. DIV 7 neurons were transfected with Lipofectamine 2000 and
1–4 mg DNA per 6 cm culture dish. For cytosolic extracts, cortical neu-
rons were lysed in Lysis Buffer 150 and fractionated as above. That
these extracts were not significantly contaminated with nuclear mate-
rial was confirmed by western blotting (Figure S4B). BDNF treatmentconsisted of a 6 hr incubation of DIV7-9 neurons with 100 ng/ml
BDNF in growth medium. HeLa and PC-12 cells were cultured accord-
ing to ATCC guidelines. PC-12 cells (33 106) were transfected by elec-
troporation (Amaxa) with 10 mg of indicated plasmids. Protein samples
were prepared by forcing cells in 1% SDS through a 25 gauge needle
followed by 5 min at 95C. Except for neurons in Figures 1D, 5A, 5B,
and 5C, which were analyzed at 24 hr, all transfection experiments
were analyzed 48 hr posttransfection.
Immunofluorescence and FISH of Cultured Neurons
Paraformaldehyde-fixedDIV 7 neurons were permeabilized, incubated
with either primary antibodies or digoxigenin-labeled RNA probes,
and then incubated with secondary antibodies followed by extensive
washing. Following staining for DNA (Hoechst dye), samples were
mounted in DABCO media. Details on these procedures, as well as
immunofluorescence of fixed hippocampal slices and detection of
surface GluR1, are described in Supplemental Data.
Semiquantitative RT-PCR
RT-PCR analyses employed the Superscript III One-Step RT-PCR kit.
Different transcripts required different amounts of input cellular RNA
to be in the linear range after 24 rounds of PCR: 0.1 ng/ul for gapdh;
1 ng/ul for map1 and other dendritic mRNAs; and 10 ng/ul for arc
mRNA. That reactions were quantitative was verified using two differ-
ent dilutions of starting RNA. All RT-PCR experiments were performed
at least two times on independently prepared samples, and results
were averaged. All RNA samples were extracted using Trireagent
and treated with RQ DNase I prior to RT-PCR analyses.
Immunoprecipitations
Cytosolic extracts (4–6 mg total protein per sample) were precleared
by two incubations with protein G agarose beads, incubated with
either a-4AIII or control (preimmune) serum for one hour at 4C, and
then with Protein G agarose beads (40 ml 50% slurry) overnight at
4C. Following five 30 min washes in Lysis Buffer 250, samples were
treated for either RNA or protein extraction (see Supplemental Data).
To ensure that 4AIII-precipitated transcripts were chromatin free, the
final wash included DNase I. Input samples represented one-fortieth
of the starting material for IP.
Electrophysiology
MEPSCs from pyramidal neurons were recorded and quantified as
previously described (Turrigiano et al., 1998; Watt et al., 2000). Two-
tailed t tests (corrected for multiple comparisons as appropriate)
were used to determine statistical significance. EGFP-expressing
neurons were identified via fluorescence, and recordings were then
obtained after switching to DIC. Recordings were discarded if resting
potentials were >55 mV, input resistances were <200 MU, or either
parameter changed more than 10% during the course of recording.
Only neurons from which >25 mEPSCs were obtained were included.
Recordings from untransfected neurons and from neurons transfected
with the control-RNAi plasmid were indistinguishable in terms of cellu-
lar and mEPSC properties and were combined.
Supplemental Data
Supplemental Data include Experimental Procedures, six figures, one
table, and one spreadsheet and can be found with this article online at
http://www.cell.com/cgi/content/full/130/1/179/DC1/.
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